Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial

Issued Date

2022-10-01

Resource Type

Letter

ISSN

01634453

eISSN

15322742

DOI

10.1016/j.jinf.2022.06.014

Scopus ID

2-s2.0-85137277797

Pubmed ID

35728642

Journal Title

Journal of Infection

Volume

85

Issue

4

Start Page

436

End Page

480

Rights Holder(s)

SCOPUS

Bibliographic Citation

Journal of Infection Vol.85 No.4 (2022) , 436-480

Suggested Citation

Niyomnaitham S., Toh Z.Q., Licciardi P.V., Wongprompitak P., Srisutthisamphan K., Copeland K.K., Chokephaibulkit K. Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial. Journal of Infection Vol.85 No.4 (2022) , 436-480. 480. doi:10.1016/j.jinf.2022.06.014 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/85499

Title

Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial

Author(s)

Niyomnaitham S.
 Toh Z.Q.
 Licciardi P.V.
 Wongprompitak P.
 Srisutthisamphan K.
 Copeland K.K.
 Chokephaibulkit K.

Author's Affiliation

Siriraj Hospital
 University of Melbourne
 Mahidol University
 Thailand National Center for Genetic Engineering and Biotechnology
 Murdoch Children's Research Institute

Other Contributor(s)

Mahidol University

Keyword(s)

Medicine

Availability

URI

https://repository.li.mahidol.ac.th/handle/20.500.14594/85499

Collections

Scopus 2022